Medical News
Fatal Outcome in Single-Patient Gene Editing Trial Raises Safety Concerns
A 6-year-old girl died seven days after receiving a personalised base-editing therapy for a rare genetic disorder in an unregistered Chinese trial, prompting international concern about oversight.
